Adrian Rawcliffe
Chief Financial Officer, HUMAN GENOME SCIENCES INC.
Companies
- Adaptimmune (United Kingdom)Board member Sep 3, 2019 to now1
- Adaptimmune (United Kingdom)Chief executive officer Sep 3, 2019 to now1
- Wave Life SciencesBoard member Feb 1, 2017 to now2
- Adaptimmune (United Kingdom)Chief financial officer Jan 4, 2016 to Sep 3, 20193
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Adaptimmune (United Kingdom) ADAPY44,327 shares4$1.4K at $0.03Jan 17, 2025
- Wave Life Sciences WVE0 shares5Aug 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 12, 2026Sold 12,700 shares at $5.29 of Wave Life Sciences5
- Dec 8, 2025Sold 42,000 shares at $15.00 of Wave Life Sciences6
- Dec 8, 2025Exercised options 42,000 shares at $5.97 of Wave Life Sciences6
- Nov 13, 2025Sold 16,115 shares at $6.79 of Wave Life Sciences7
- Aug 11, 2025Granted 12,700 shares of Wave Life Sciences8
- Jan 17, 2025Sold 30,601 shares at $0.58 of Adaptimmune (United Kingdom)4
- Jan 15, 2025Sold 29,096 shares at $0.57 of Adaptimmune (United Kingdom)9
- Jan 13, 2025Sold 17,934 shares at $0.59 of Adaptimmune (United Kingdom)9
- Jan 13, 2025Sold 12,539 shares at $0.59 of Adaptimmune (United Kingdom)9
- Aug 12, 2024Granted 16,115 shares of Wave Life Sciences10
- Jan 17, 2024Sold 30,080 shares at $0.67 of Adaptimmune (United Kingdom)11
- Jan 16, 2024Sold 9,304 shares at $0.79 of Adaptimmune (United Kingdom)11
- Jan 12, 2024Sold 17,257 shares at $0.85 of Adaptimmune (United Kingdom)12
- Jan 11, 2024Sold 11,945 shares at $0.84 of Adaptimmune (United Kingdom)12
- Sep 1, 2023Sold 2,403 shares at $0.78 of Adaptimmune (United Kingdom)13
- Jun 27, 2023Sold 2,333 shares at $0.92 of Adaptimmune (United Kingdom)14
- Jan 17, 2023Sold 10,057 shares at $1.86 of Adaptimmune (United Kingdom)15
- Jan 12, 2023Sold 18,763 shares at $1.71 of Adaptimmune (United Kingdom)16
- Jan 11, 2023Sold 13,042 shares at $1.75 of Adaptimmune (United Kingdom)16
- Jan 4, 2023Sold 5,073 shares at $1.69 of Adaptimmune (United Kingdom)17
- Sep 1, 2022Sold 2,536 shares at $1.97 of Adaptimmune (United Kingdom)18
- Jun 27, 2022Sold 2,562 shares at $1.63 of Adaptimmune (United Kingdom)19
- Jan 18, 2022Sold 11,096 shares at $3.19 of Adaptimmune (United Kingdom)20
- Jan 12, 2022Sold 3,046 shares at $3.54 of Adaptimmune (United Kingdom)21
- Jan 11, 2022Sold 14,362 shares at $3.56 of Adaptimmune (United Kingdom)21
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARWave Life Sciences, Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Dec 10, 2025
- 7SEC EDGARForm 4 filed Nov 14, 2025
- 8SEC EDGARForm 4 filed Aug 13, 2025
- 9SEC EDGARForm 4 filed Jan 15, 2025
- 10SEC EDGARForm 4 filed Aug 14, 2024
- 11SEC EDGARForm 4 filed Jan 17, 2024
- 12SEC EDGARForm 4 filed Jan 12, 2024
- 13SEC EDGARForm 4 filed Sep 1, 2023
- 14SEC EDGARForm 4 filed Jun 27, 2023
- 15SEC EDGARForm 4 filed Jan 17, 2023
- 16SEC EDGARForm 4 filed Jan 12, 2023
- 17SEC EDGARForm 4 filed Jan 4, 2023
- 18SEC EDGARForm 4 filed Sep 1, 2022
- 19SEC EDGARForm 4 filed Jun 27, 2022
- 20SEC EDGARForm 4 filed Jan 18, 2022
- 21SEC EDGARForm 4 filed Jan 13, 2022